Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.
Vertex Pharmaceuticals and Orna Therapeutics announce a $4 billion collaboration to develop in vivo gene editing therapies ...
Finbold has selected three interesting pharmaceutical stocks that could see significant moves to the upside in 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback